Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Science Daily3d
Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
Researchers say new drug could stop Alzheimer's in its tracks
Researchers say a new drug could stop Alzheimer's in its tracksResearchers have hailed a promising breakthrough in the ...
Neuroscience News3d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
News Medical3d
Researchers make breakthrough in Alzheimer's disease drug development
The research, published in Alzheimer's & Dementia ... we have a drug which is effective in inhibiting both these regions. This dual-targeting mechanism is significant because it addresses both ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Hosted on MSN1d
SGLT-2 Inhibitors May Lower Dementia Risk in Type 2 Diabetes Patients, Study Finds
Numerous mechanisms have been found linking dementia and type 2 diabetes, including vascular compromise, hypoglycemia, and insulin resistance. Therefore, anti-glycemic drugs could potentially have ...
The Sun3d
Breakthrough Alzheimer’s drug successfully blocks both major disease ‘hotspots’ at once for the first time
"For the first time, we have a drug which is effective in inhibiting both these regions. "This dual-targeting mechanism is significant ... test that could predict dementia up to nine years ...